Improvement of Clostridium tumour targeting vectors evaluated in rat rhabdomyosarcomas

J Theys; W Landuyt; S Nuyts; L Van Mellaert; E Bosmans; A Rijnders; W Van den Bogaert; A van Oosterom; J Anne; P Lambin

doi:10.1016/S0928-8244(00)00231-5

Improvement of Clostridium tumour targeting vectors evaluated in rat rhabdomyosarcomas

J Theys, W Landuyt, S Nuyts, L Van Mellaert, E Bosmans, A Rijnders, W Van den Bogaert, A van Oosterom, J Anne, P Lambin^*

^*Corresponding author for this work

GROW - Innovative Cancer Diagnostics & Therapy

Research output: Contribution to journal › Article › Academic › peer-review

6 Downloads (Pure)

Abstract

Previous studies have demonstrated the feasibility of using apathogenic clostridia as a promising strategy for hypoxia-specific tumour targeting. The present study shows that the use of the vascular targeting compound combretastatin A-4 phosphate could significantly (P

Original language	English
Pages (from-to)	37-41
Number of pages	5
Journal	Fems Immunology and Medical Microbiology
Volume	30
Issue number	1
DOIs	https://doi.org/10.1016/S0928-8244(00)00231-5
Publication status	Published - Feb 2001

Keywords

anti-cancer treatment
gene therapy
hypoxia
vascular targeting
Clostridium
COMBRETASTATIN A-4
VASCULATURE
PHOSPHATE
BACTERIA
THERAPY
ALPHA

Access to Document

10.1016/S0928-8244(00)00231-5

Full TextFinal published version, 293 KBLicence: Taverne

Cite this

@article{8e7e7b9cf53e449dab56c10a1eaee61f,

title = "Improvement of Clostridium tumour targeting vectors evaluated in rat rhabdomyosarcomas",

abstract = "Previous studies have demonstrated the feasibility of using apathogenic clostridia as a promising strategy for hypoxia-specific tumour targeting. The present study shows that the use of the vascular targeting compound combretastatin A-4 phosphate could significantly (P",

keywords = "anti-cancer treatment, gene therapy, hypoxia, vascular targeting, Clostridium, COMBRETASTATIN A-4, VASCULATURE, PHOSPHATE, BACTERIA, THERAPY, ALPHA",

author = "J Theys and W Landuyt and S Nuyts and {Van Mellaert}, L and E Bosmans and A Rijnders and {Van den Bogaert}, W and {van Oosterom}, A and J Anne and P Lambin",

year = "2001",

month = feb,

doi = "10.1016/S0928-8244(00)00231-5",

language = "English",

volume = "30",

pages = "37--41",

journal = "Fems Immunology and Medical Microbiology",

issn = "0928-8244",

publisher = "Wiley-Blackwell",

number = "1",

}

TY - JOUR

T1 - Improvement of Clostridium tumour targeting vectors evaluated in rat rhabdomyosarcomas

AU - Theys, J

AU - Landuyt, W

AU - Nuyts, S

AU - Van Mellaert, L

AU - Bosmans, E

AU - Rijnders, A

AU - Van den Bogaert, W

AU - van Oosterom, A

AU - Anne, J

AU - Lambin, P

PY - 2001/2

Y1 - 2001/2

N2 - Previous studies have demonstrated the feasibility of using apathogenic clostridia as a promising strategy for hypoxia-specific tumour targeting. The present study shows that the use of the vascular targeting compound combretastatin A-4 phosphate could significantly (P

AB - Previous studies have demonstrated the feasibility of using apathogenic clostridia as a promising strategy for hypoxia-specific tumour targeting. The present study shows that the use of the vascular targeting compound combretastatin A-4 phosphate could significantly (P

KW - anti-cancer treatment

KW - gene therapy

KW - hypoxia

KW - vascular targeting

KW - Clostridium

KW - COMBRETASTATIN A-4

KW - VASCULATURE

KW - PHOSPHATE

KW - BACTERIA

KW - THERAPY

KW - ALPHA

U2 - 10.1016/S0928-8244(00)00231-5

DO - 10.1016/S0928-8244(00)00231-5

M3 - Article

SN - 0928-8244

VL - 30

SP - 37

EP - 41

JO - Fems Immunology and Medical Microbiology

JF - Fems Immunology and Medical Microbiology

IS - 1

ER -

Improvement of Clostridium tumour targeting vectors evaluated in rat rhabdomyosarcomas

Abstract

Keywords

Access to Document

Fingerprint

Cite this